Next Article in Journal
New TMA (4,6,4′-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease
Next Article in Special Issue
A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins—UBL3
Previous Article in Journal
Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
Previous Article in Special Issue
Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2022, 23(22), 14480; https://doi.org/10.3390/ijms232214480
Action Date Notes Link
article pdf uploaded. 21 November 2022 13:26 CET Version of Record https://www.mdpi.com/1422-0067/23/22/14480/pdf-vor
article xml file uploaded 23 November 2022 07:58 CET Original file -
article xml uploaded. 23 November 2022 07:58 CET Update https://www.mdpi.com/1422-0067/23/22/14480/xml
article pdf uploaded. 23 November 2022 07:58 CET Updated version of record https://www.mdpi.com/1422-0067/23/22/14480/pdf
article html file updated 23 November 2022 07:59 CET Original file -
article html file updated 23 November 2022 07:59 CET Update -
article html file updated 1 March 2023 00:07 CET Update -
article html file updated 3 March 2023 21:43 CET Update https://www.mdpi.com/1422-0067/23/22/14480/html
Back to TopTop